Author Archives: Jennifer Ringler

Cause and Effect—Sales Rep Visits and Physician Prescribing Habits

By Jennifer Ringler | Published: June 11, 2012
A new study suggests that physicians who see fewer reps are slower when it comes to dropping ‘black-box’ drugs—and at adopting promising new medications. If you’ve ever had any doubts about whether your sales reps are actually affecting the prescribing habits of the physicians they visit, a new report by ZS Associates, recently reported on in [...]
Posted in Marketing, Sales, healthcare | Tagged , , , | 1 Comment

Show Me the Money: Exploring Physician Incentive Compensation

By Jennifer Ringler | Published: May 21, 2012
A new report from ZS Associates explores the efficacy and impact of physician incentive compensation on the delivery of quality care; when incentives fall short, so can patient outcomes.
Posted in Op-Ed, Strategy | Tagged , , | Leave a comment

Going the Distance in Digital Advertising

By Jennifer Ringler | Published: May 9, 2012
For pharma, simply moving traditional marketing materials and tactics from print to online is not enough—a true digital transition must be interactive to be effective. According to a new report from comScore, which works with health industry marketers to quantify the success of their online programs and provides competitive intelligence and benchmarking solutions, the most effective [...]
Posted in Advertising, Legal, Marketing | Tagged , , | Leave a comment

Join the Adherence Conversation

By Jennifer Ringler | Published: April 6, 2012
Medication adherence is an ongoing and serious problem; according to the Center for Health Transformation, the annual cost of patients not taking their medicines as prescribed is nearly $300 billion, with approximately 125,000 patients dying each year due to poor adherence—that’s 342 people every day. Improving adherence rates in the United States has been a [...]
Posted in Events | Tagged , | Leave a comment

Rare Diseases Lead to Unique Legislation

By Jennifer Ringler | Published: February 29, 2012
Since 1983, pharma and patent organizations have been working together to influence policy aimed at improving the lives of those with rare diseases. In 1983—with the help of Abbey Meyers and the drive she had to help her son (more on that here)—the Orphan Drug Act was passed to incentivize pharma to step up and play [...]
Posted in Events, Global, Legal | Tagged , , , , , , | Leave a comment